Revolution Medicines

Senior Director, Head of Search & Evaluation

Redwood City, California, United States · Director · Full-time

Sponsorship not specified$244k-$305kDetected 1 day ago

ComplianceBusiness DevelopmentNegotiationIntellectual PropertyResearchLeadershipCommunicationCollaboration

About the role

The successful candidate will combine deep scientific and business acumen with strong leadership, analytical, and communication skills.
This individual will serve as a key connector across the organization, ensuring that external innovation efforts are aligned with corporate strategy, therapeutic area priorities, and emerging opportunities in precision oncology and related fields.
External Innovation Strategy and Opportunity Identification

Develop and execute search strategies that align with Revolution Medicines' research, development, and commercial priorities.
Drive proactive opportunity sourcing through engagement with biotechnology companies, academic institutions, investors, entrepreneurs, and other innovation ecosystems.
Partner with Portfolio Management, Disease Strategy, Research, and Development leaders to identify areas where external innovation can create strategic value and enhance portfolio competitiveness.
Maintain a comprehensive understanding of relevant scientific, clinical, and competitive landscapes to identify emerging opportunities and trends.
Develop balanced recommendations regarding prioritization, resource allocation, and partnership strategy.
Drive opportunities through evaluation and governance processes, ensuring efficient review, transparency, and organizational alignment.
Partner with Portfolio Management and Business Development leadership to align external innovation activities with evolving corporate priorities.
Support portfolio planning efforts through identification and assessment of external opportunities that address strategic gaps or accelerate growth objectives.
Support negotiation preparation and executive decision-making by providing scientific, clinical, commercial, and strategic context for opportunities under consideration.

Experience in precision oncology, targeted therapeutics, or related therapeutic areas.
Prior leadership experience within business development, search and evaluation, corporate strategy, portfolio strategy, or external innovation functions.
Experience working in both large pharmaceutical and biotechnology environments.
Established network across biotechnology, pharmaceutical, venture capital, and academic communities.
Demonstrated success influencing portfolio strategy and external innovation priorities.
Leadership Competencies
Successful candidates will demonstrate:
Scientific and strategic leadership.

Ensure key risks, opportunities, and strategic considerations are thoroughly evaluated and clearly communicated to decision-makers.

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.
The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins.
The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
Lead the company's search and evaluation of external innovation in partnership with senior cross-functional stakeholders.

This listing is sourced directly from Revolution Medicines's careers page and normalized into a canonical job model.